VAPRED Study

Revision as of 15:27, 25 September 2013 by Rim Halaby (talk | contribs) (Created page with "__NOTOC__ {{D-dimer}} {{CMG}} ==Official Title== ==Objective== ==Sponsor== ==Timeline== {| class="wikitable" border="1" style="background:WhiteSmoke" width="40%" |- | C...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

D-Dimer Microchapters

Home

Patient information

Overview

Historical Perspective

Physiology

Clinical Correlation

Causes of High D-dimer

Diagnostic Role in Thromboembolism

Prognostic Role in Mortality

Prognostic Role in Thromboembolism Occurence

Prognostic Role in Thromboembolism Recurrence

Prognostic Role in Non-Thromboembolism

Clinical Trials

Landmark Trials

Case #1

VAPRED Study On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of VAPRED Study

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on VAPRED Study

CDC on VAPRED Study

VAPRED Study in the news

Blogs on VAPRED Study

Directions to Hospitals Treating D-dimer

Risk calculators and risk factors for VAPRED Study

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Official Title

Objective

Timeline

Timeline
Start Date
Run-In Period
End Date
Status

The previous information was derived from ClinicalTrials.gov on 09/20/2013 using the identification number NCT------.

Study Description

Study Description
Study Type
Study Phase
Study Design
Allocation
Endpoint
Interventional Model
Masking
Study Details
Primary Purpose
Condition
Intervention
Study Arms
Population Size

The previous information was derived from ClinicalTrials.gov on 09/20/2013 using the identification number NCT-----.

Eligibility Criteria

Inclusion Criteria

Exclusion Criteria

Outcomes

Primary Outcomes

Secondary Outcomes

Publications

Results

Conclusion

References

Template:WH Template:WS